Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939883A discloses a metal-free visible light catalyzed method for polysubstituted 1,3-oxazolidines. High yield, mild conditions, cost-effective for pharma intermediates.
Patent CN107353245A enables metal-free quinoline production. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118459319A introduces visible light catalysis for biphenols. Offers green synthesis, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Novel photosensitizer-free method for 2-amino-1,4-naphthoquinone derivatives offering green synthesis and supply chain efficiency for pharmaceutical intermediates.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.
Patent CN107899611A enables visible light asymmetric hydroxylation using molecular oxygen. Delivers cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN107899611A introduces a visible light organocatalyst for asymmetric hydroxylation, offering cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN110105293B details a visible-light driven method for synthesizing C-3 difluoromethyl quinoxalinones, offering a greener, safer route for pharmaceutical intermediate manufacturing.
Patent CN118373733A reveals a novel visible-light organophosphine catalyzed route for high-purity difluorostyrene derivatives, offering significant supply chain and cost advantages.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Novel visible-light induced method for quinoxalines using non-activated amines. Cost-effective, green synthesis for reliable pharmaceutical intermediate supply chain.
Patent CN118851967A details a green visible light method for trifluoromethylselenosylstyrene derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110386854A reveals a metal-free photoredox method for aryl alkynes. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN115894345A reveals a metal-free visible light method for chiral azaarene cyclobutanes, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN110467585A introduces a mild visible light method for benzothiazole derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN116947830A reveals metal-free visible light synthesis for coumarin heterocycles, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118955504B reveals visible light cobalt catalysis for hexahydro beta carboline indole compounds offering safer greener pharmaceutical intermediate manufacturing supply chain advantages.
Patent CN110590774B discloses a green photocatalytic method for C3-trifluoromethylation of imidazo-fused rings, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN110590774B details a green photocatalytic route for C3-trifluoromethylation, offering mild conditions and high purity for pharmaceutical intermediates.